Phone: (011) 7541-421, 3409-301, 3409-335, 6547-293, 3409-310
E-mail: Standards sales: prodaja@iss.rs Education: iss-edukacija@iss.rs Information about standards: infocentar@iss.rs
Stevana Brakusa 2, 11030 Beograd
Main menu

dnaSRPS CEN ISO/TS 5798:2023

In vitro diagnostic test systems - Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods (ISO/TS 5798:2022)

General information

50.99     Mar 21, 2023

ISS

Z076

Technical Specification

11.100.01  

Scope

This document provides requirements and recommendations for the design, development, verification, validation and implementation of analytical tests for detecting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using nucleic acid amplification. It addresses pre-examination, examination and post-examination process steps for human specimens.
This document is applicable to medical laboratories. It is also intended to be used by in vitro diagnostic developers and manufacturers, as well as by institutions and organizations supporting SARS-CoV-2 research and diagnostics.
This document does not apply to environmental samples.

Life cycle

NOW

PROJECT
dnaSRPS CEN ISO/TS 5798:2023
50.99 FDIS or proof approved for publication
Mar 21, 2023

Related project

Adopted from CEN ISO/TS 5798:2022 IDENTICAL

Adopted from ISO/TS 5798:2022 IDENTICAL